Inovio Pharmaceuticals (INO) Non Operating Income (2018 - 2025)
Historic Non Operating Income for Inovio Pharmaceuticals (INO) over the last 11 years, with Q3 2025 value amounting to -$1.9 million.
- Inovio Pharmaceuticals' Non Operating Income fell 23428.29% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.6 million, marking a year-over-year decrease of 11514.62%. This contributed to the annual value of -$3.2 million for FY2024, which is 3285.27% up from last year.
- According to the latest figures from Q3 2025, Inovio Pharmaceuticals' Non Operating Income is -$1.9 million, which was down 23428.29% from -$703183.0 recorded in Q2 2025.
- In the past 5 years, Inovio Pharmaceuticals' Non Operating Income registered a high of $185281.0 during Q2 2021, and its lowest value of -$2.8 million during Q4 2022.
- Its 5-year average for Non Operating Income is -$738706.4, with a median of -$579819.0 in 2024.
- In the last 5 years, Inovio Pharmaceuticals' Non Operating Income skyrocketed by 179944.39% in 2021 and then crashed by 4674603.02% in 2023.
- Quarter analysis of 5 years shows Inovio Pharmaceuticals' Non Operating Income stood at $177598.0 in 2021, then crashed by 1656.49% to -$2.8 million in 2022, then skyrocketed by 68.86% to -$860908.0 in 2023, then crashed by 121.77% to -$1.9 million in 2024, then decreased by 1.52% to -$1.9 million in 2025.
- Its last three reported values are -$1.9 million in Q3 2025, -$703183.0 for Q2 2025, and -$482.0 during Q1 2025.